ArticleScientific reports2018

Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation.

Alicia Bort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.